Tc Biopharm Plc Stock Analysis
| TCBPW Stock | USD 0.01 0 18.67% |
TC BioPharm plc is overvalued with Real Value of 0.0104 and Hype Value of 0.0128. The main objective of TC BioPharm stock analysis is to determine its intrinsic value, which is an estimate of what TC BioPharm plc is worth, separate from its market price. There are two main types of TC BioPharm's stock analysis: fundamental analysis and technical analysis.
The TC BioPharm stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. TC BioPharm is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. TCBPW Stock trading window is adjusted to America/New York timezone.
TCBPW |
TCBPW Stock Analysis Notes
The company recorded a loss per share of 0.75. TC BioPharm plc had not issued any dividends in recent years. The entity had 1:50 split on the 21st of November 2022. TC Biopharm Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom. Tc Biopharm operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 74 people. To find out more about TC BioPharm plc contact Bryan Kobel at 44 14 1433 7557 or learn more at https://tcbiopharm.com.TC BioPharm plc Investment Alerts
| TC BioPharm plc is way too risky over 90 days horizon | |
| TC BioPharm plc has some characteristics of a very speculative penny stock | |
| TC BioPharm plc appears to be risky and price may revert if volatility continues | |
| TC BioPharm plc has a very high chance of going through financial distress in the upcoming years | |
| TC BioPharm plc has accumulated 1.8 M in total debt. TC BioPharm plc has a current ratio of 0.18, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about TC BioPharm's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (5.91 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| TC BioPharm plc has accumulated about 1.55 M in cash with (10.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| TC BioPharm plc has a very weak financial position based on the latest SEC disclosures |
TC BioPharm Thematic Classifications
In addition to having TC BioPharm stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | BiotechBiotechnology and pharmaceuticals production and services |
Technical Drivers
As of the 31st of January, TC BioPharm owns the market risk adjusted performance of 0.8831, and Standard Deviation of 20.55. In connection with fundamental indicators, the technical analysis model makes it possible for you to check timely technical drivers of TC BioPharm plc, as well as the relationship between them. Please validate TC BioPharm plc standard deviation, as well as the relationship between the value at risk and kurtosis to decide if TC BioPharm plc is priced adequately, providing market reflects its prevailing price of 0.0122 per share. As TC BioPharm plc appears to be a penny stock we also recommend to double-check its total risk alpha numbers.TC BioPharm plc Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. TC BioPharm middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for TC BioPharm plc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
TC BioPharm Predictive Daily Indicators
TC BioPharm intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of TC BioPharm stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 98.51 | |||
| Daily Balance Of Power | (2.33) | |||
| Rate Of Daily Change | 0.81 | |||
| Day Median Price | 0.0128 | |||
| Day Typical Price | 0.0126 | |||
| Price Action Indicator | (0) | |||
| Period Momentum Indicator | (0) |
TC BioPharm Forecast Models
TC BioPharm's time-series forecasting models are one of many TC BioPharm's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary TC BioPharm's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About TCBPW Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how TC BioPharm prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling TCBPW shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as TC BioPharm. By using and applying TCBPW Stock analysis, traders can create a robust methodology for identifying TCBPW entry and exit points for their positions.
TC Biopharm Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom. Tc Biopharm operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 74 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding TC BioPharm to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Correlation Analysis Now
Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated |
| All Next | Launch Module |
Additional Tools for TCBPW Stock Analysis
When running TC BioPharm's price analysis, check to measure TC BioPharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TC BioPharm is operating at the current time. Most of TC BioPharm's value examination focuses on studying past and present price action to predict the probability of TC BioPharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TC BioPharm's price. Additionally, you may evaluate how the addition of TC BioPharm to your portfolios can decrease your overall portfolio volatility.